STOCK TITAN

Synergy CHC Announces New $20 Million Long-Term Credit Facility

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Synergy CHC Corp. (NASDAQ: SNYR) has secured a $20 million term loan credit agreement with ACP Agency, LLC, extending through May 2029. The company received $15 million upfront at SOFR plus 8.5% interest rate, with interest-only payments through 2025. Starting January 2026, quarterly principal payments begin at $175,000, increasing to $350,000 per quarter from 2027. The facility includes a $2.5 million delayed draw facility and $2.5 million uncommitted term loan incremental facility. The refinancing aims to strengthen Synergy's capital structure, repay existing debt, and provide growth capital. The company will use the delayed draw proceeds to fully repay debt related to settlement agreements.
Synergy CHC Corp. (NASDAQ: SNYR) ha ottenuto un accordo di finanziamento a termine da 20 milioni di dollari con ACP Agency, LLC, valido fino a maggio 2029. L'azienda ha ricevuto 15 milioni di dollari immediatamente, con un tasso di interesse pari a SOFR più l'8,5%, pagando solo gli interessi fino al 2025. Da gennaio 2026 inizieranno i pagamenti trimestrali del capitale, partendo da 175.000 dollari e aumentando a 350.000 dollari per trimestre dal 2027. Il finanziamento include una linea di credito a prelievo differito da 2,5 milioni di dollari e una linea di prestito a termine incrementale non vincolante da 2,5 milioni di dollari. La rifinanziamento mira a rafforzare la struttura finanziaria di Synergy, rimborsare il debito esistente e fornire capitale per la crescita. L'azienda utilizzerà i fondi del prelievo differito per estinguere completamente il debito relativo ad accordi di risoluzione.
Synergy CHC Corp. (NASDAQ: SNYR) ha asegurado un acuerdo de crédito a plazo de 20 millones de dólares con ACP Agency, LLC, vigente hasta mayo de 2029. La compañía recibió 15 millones de dólares por adelantado con una tasa de interés de SOFR más 8.5%, realizando solo pagos de intereses hasta 2025. A partir de enero de 2026, comenzarán los pagos trimestrales de capital, iniciando en 175,000 dólares y aumentando a 350,000 dólares por trimestre desde 2027. La facilidad incluye una línea de crédito de desembolso diferido de 2.5 millones de dólares y una línea de préstamo a término incremental no comprometida de 2.5 millones de dólares. La refinanciación tiene como objetivo fortalecer la estructura de capital de Synergy, pagar la deuda existente y proporcionar capital para el crecimiento. La compañía usará los fondos del desembolso diferido para pagar completamente la deuda relacionada con acuerdos de conciliación.
Synergy CHC Corp. (NASDAQ: SNYR)는 ACP Agency, LLC와 2029년 5월까지 유효한 2,000만 달러의 기한부 대출 신용 계약을 체결했습니다. 회사는 SOFR에 8.5% 이자를 더한 금리로 1,500만 달러를 선지급 받았으며, 2025년까지 이자만 납부합니다. 2026년 1월부터 분기별 원금 상환이 시작되며, 처음에는 분기당 175,000달러이고 2027년부터는 분기당 350,000달러로 증가합니다. 이 금융 시설에는 250만 달러의 지연 인출 시설과 250만 달러의 비확정 기한부 대출 증액 시설이 포함되어 있습니다. 이번 재융자는 Synergy의 자본 구조를 강화하고 기존 부채를 상환하며 성장 자본을 제공하는 것을 목표로 합니다. 회사는 지연 인출 자금을 사용해 합의 계약 관련 부채를 전액 상환할 예정입니다.
Synergy CHC Corp. (NASDAQ : SNYR) a conclu un accord de prêt à terme de 20 millions de dollars avec ACP Agency, LLC, valable jusqu'en mai 2029. La société a reçu 15 millions de dollars immédiatement, au taux SOFR plus 8,5 % d'intérêt, avec des paiements d'intérêts uniquement jusqu'en 2025. À partir de janvier 2026, les remboursements trimestriels du principal débuteront à 175 000 dollars, augmentant à 350 000 dollars par trimestre à partir de 2027. Cette facilité comprend une ligne de tirage différé de 2,5 millions de dollars et une facilité de prêt à terme incrémentale non engagée de 2,5 millions de dollars. Le refinancement vise à renforcer la structure du capital de Synergy, rembourser la dette existante et fournir des fonds de croissance. La société utilisera les fonds du tirage différé pour rembourser intégralement la dette liée aux accords de règlement.
Synergy CHC Corp. (NASDAQ: SNYR) hat eine Kreditvereinbarung über einen Terminkredit in Höhe von 20 Millionen US-Dollar mit ACP Agency, LLC abgeschlossen, der bis Mai 2029 läuft. Das Unternehmen erhielt 15 Millionen US-Dollar im Voraus zu einem Zinssatz von SOFR plus 8,5 % und zahlt bis 2025 nur Zinsen. Ab Januar 2026 beginnen vierteljährliche Tilgungszahlungen in Höhe von 175.000 US-Dollar, die ab 2027 auf 350.000 US-Dollar pro Quartal steigen. Die Finanzierung beinhaltet eine verzögerte Abruffazilität von 2,5 Millionen US-Dollar sowie eine ungebundene zusätzliche Terminkreditfazilität von 2,5 Millionen US-Dollar. Die Refinanzierung soll die Kapitalstruktur von Synergy stärken, bestehende Schulden tilgen und Wachstumskapital bereitstellen. Das Unternehmen wird die Mittel aus der verzögerten Abruffazilität verwenden, um Schulden aus Vergleichsvereinbarungen vollständig zurückzuzahlen.
Positive
  • Secured long-term financing through 2029 providing financial stability
  • Interest-only payments through 2025 improving near-term cash flow
  • Access to additional $5 million through delayed draw and incremental facilities
  • Debt refinancing strengthens capital structure and provides growth capital
Negative
  • High interest rate at SOFR plus 8.5%
  • Increasing quarterly principal payment obligations starting 2026
  • Existence of settlement agreements requiring debt repayment indicates previous issues

WESTBROOK, Maine, June 04, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it has entered into a $20 million term loan credit agreement, due May 2029 with ACP Agency, LLC. The proceeds will be used to pay down debt and provide the Company with growth capital.

Under the terms of the agreement, the Company received a $15 million term loan at closing, with an interest rate of SOFR plus 8.5%. The loan is interest-only through 2025, with quarterly principal payments of $175,000 beginning in January 2026, increasing to $350,000 per quarter in 2027 and beyond.

A $2.5 million delayed draw facility and $2.5 million uncommitted term loan incremental facility are also available to the Company.

“We are very pleased to have completed our debt refinancing, which supports our growth strategy and significantly strengthens our capital structure,” said Jack Ross, CEO of Synergy. “The long-term nature of the new facility enhances our balance sheet and provides the flexibility needed for our next phase of growth. Additionally, the delayed draw proceeds allow us to fully repay debt related to settlement agreements, positioning us for greater financial stability as we execute our strategic goals.”

About Synergy CHC Corp.

Synergy CHC Corp. is a provider of consumer health care and lifestyle products. Synergy's current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement that has been shown to improve memory, concentration and focus, and Flat Tummy, a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their weight management goals.

Investor Relations

Gateway Group
Cody Slach, Greg Robles
949.574.3860
SNYR@gateway-grp.com


FAQ

What is the size and terms of SNYR's new credit facility?

SNYR secured a $20 million credit facility due May 2029, with $15 million received upfront at SOFR plus 8.5% interest rate. The facility includes interest-only payments through 2025 and quarterly principal payments starting 2026.

How will Synergy CHC use the proceeds from the new credit facility?

The proceeds will be used to pay down existing debt, repay settlement-related debt through the delayed draw facility, and provide growth capital for the company.

What are the payment terms for SNYR's new credit facility?

The loan is interest-only through 2025, with quarterly principal payments of $175,000 beginning January 2026, increasing to $350,000 per quarter from 2027 onwards.

What additional funding options are available in SNYR's credit facility?

The facility includes a $2.5 million delayed draw facility and a $2.5 million uncommitted term loan incremental facility.

When does Synergy CHC's new credit facility mature?

The credit facility matures in May 2029.
Synergy Chc Corp

NASDAQ:SNYR

SNYR Rankings

SNYR Latest News

SNYR Stock Data

16.68M
2.71M
72.42%
12.27%
0.1%
Medical Distribution
Medicinal Chemicals & Botanical Products
Link
United States
WESTBROOK